Skip to content

Duke University government contracts

$573M obligated across 71 federal awards. 33 are still running.

UEI TP7EK8DZV6N5Latest award Sep 30, 2026

Who buys from Duke University

AgencyAwardsObligated
National Institutes of Health50$494M
Health Resources and Services Administration1$31M
Centers for Disease Control and Prevention8$16.9M
DHS Office of Procurement Operations1$9.3M
Administration for Children and Families1$5.4M
Interior Departmental Offices1$5M
Food and Drug Administration3$4.3M
Defense Health Agency1$3M
Department of Veterans Affairs1$2.3M
Department of the Army1$1.9M

What Duke University sells

Its awards by NAICS code. Codes with live notices link to them.

Contracts ending soon

Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.

AwardObligatedStartEnd
IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM

National Institutes of Health · 75N93021C00010

$9.1MSep 30, 2021Sep 29, 2026
THIS ACQUISITION IS FOR COMMERCIAL OPERATION AND MAINTENANCE SUPPORT SERVICES FOR THE NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) DATABASE. THE ACF IS THE AGENCY WITHIN HHS THAT IS RESPONSIBLE FOR FEDERAL PROGRAMS THAT PROMOTE

Interior Departmental Offices · 140D0422P0227

$5MSep 26, 2022Sep 29, 2026
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING

National Institutes of Health · 75N93022F00001

$2.9MDec 1, 2021Nov 30, 2026
VIROLOGY CORE LABORATORY

National Institutes of Health · 75N93025C00002

$1.9MDec 15, 2024Dec 14, 2026
RESEARCH AND DEVELOPMENT TBI AND PSYCHOLOGICAL HEALTH RESEARCH PROGRAM PROPOSAL TP210599

Defense Health Agency · W81XWH22C0123

$3MSep 30, 2022Dec 28, 2026
THE GOAL OF THIS TASK ORDER IS TO PERFORM PHARMACOEPIDEMIOLOGY RESEARCH AND A PK, PHARMACODYNAMIC, PHARMACOGENOMIC, EFFICIENCY, AND SAFETY TRIAL OF THE HIGHEST RECOMMENDED DOSE OF SILDENAFIL IN PRETERM NEONATES (COHORT 3); WITH CLINICALLY R

National Institutes of Health · 75N94022F00001

$1.5MJun 14, 2022Feb 14, 2027
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7

National Institutes of Health · 75N93024C00005

$3.5MMar 1, 2024Feb 28, 2027
THE PURPOSE OF THIS TASK ORDER IS TO (A) ACQUIRING, PROCURING AND/OR MANUFACTURING MATERIALS REQUIRED FOR THE GENERATION OF A SCALABLE IN VITRO TRANSCRIPTION (IVT) REACTION, THE PURIFICATION OF THE TRANSCRIBED MRNA, PROCUREMENT/SYNTHESIS OF

National Institutes of Health · 75N93023F00001

$6.8MAug 30, 2023Mar 28, 2027
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT

National Institutes of Health · 75N93025C00006

$5.1MMar 30, 2025Mar 29, 2027
2023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ

Centers for Disease Control and Prevention · 75D30123F00002

$2.2MSep 28, 2023May 31, 2027
HHSN275201800008I - NEW TASK ORDER PHASE 2: RECRUITMENT AND FOLLOW-UP STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) (AIMS 1 AND 2) - DUKE UNIVERSITY - CAN 8050079

National Institutes of Health · 75N94024F00002

$1.1MSep 1, 2024May 31, 2027
NICHD: R&D: BEST PHARMACEUTICALS FOR CHILDREN ACT (BPCA) PEDIATRIC TRIALS NETWORK (PTN): CORE FUNCTION ACTIVITIES - THE CONTRACTOR SHALL ESTABLISH AND MAINTAIN CENTRALIZED TEAMS OF EXPERTS WHO WILL DEVELOP PROTOCOLS AND INFORMED CONSENT FOR

National Institutes of Health · 75N94025F00001

$4.8MJun 4, 2025Jun 3, 2027

Largest awards

By total obligated value. Each links to its record on USAspending.gov.

AwardObligatedStartEnd
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE

National Institutes of Health · 75N93019C00053

$78.2MAug 26, 2019Sep 15, 2028
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABL

National Institutes of Health · 75N93019C00050

$68MSep 10, 2019Jul 28, 2027
IGF::OT::IGF EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)

National Institutes of Health · HHSN272201700061C

$35.8MAug 29, 2017Sep 29, 2024
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) - COMPONENT C: CLINICAL CORE (AWARDED POP: SEPTEMBER 16, 2019 - SEPTEMBER 15, 2020)

National Institutes of Health · 75N93019C00054

$35.6MSep 16, 2019Dec 31, 2030
NATIONAL CORD BLOOD INVENTORY

Health Resources and Services Administration · 75R60220C00008

$31MJul 10, 2020Sep 3, 2036
IGF::OT::IGF NIAID VIROLOGY QUALITY ASSURANCE (VQA)

National Institutes of Health · 75N93019C00015

$24MJun 21, 2019Jun 20, 2026
"ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES"

National Institutes of Health · 75N93022C00055

$18MSep 19, 2022May 31, 2028
IGF::OT::IGF NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT

National Institutes of Health · HHSN272201800004C

$18MMar 28, 2018Mar 29, 2025
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)

National Institutes of Health · 75N93024F00001

$12.1MSep 30, 2024Sep 29, 2027
IGF::OT::IGF1300017I DUKE UNIVERSITY; TASK ORDER HHSN27200008-14-0053.A1B1C1D1.0026- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL IN ADULTS WITH COMMUNITY ACQUIRED PNEUMONIA; BASE $141,485, OPTION 1 $67,837, OPTION 2 $4,049

National Institutes of Health · HHSN27200008

$12MJun 5, 2015Dec 31, 2024
TO PERFORM INNOVATIVE TRIAL DESIGNS WITH CLINICALLY RELEVANT OUTCOMES SUCH AS ENDPOINTS, BIOMARKERS, AND EPIDEMIOLOGY DATA INCLUDED ASPART OF EVERY PROTOCOL, TO OBTAIN COMPREHENSIVE AND COMPARATIVE ANALYSIS OF THE DATA FOR THE ADVANCE OF SC

National Institutes of Health · 75N94019F00125

$10.6MSep 12, 2019Jul 31, 2025
BPCA PHARMACOLOGY STUDIES - PERIOD OF PERFORMANCE: 9/14/18 - 9/13/22

National Institutes of Health · 75N94018F00002

$9.8MSep 11, 2018Mar 13, 2025

Similar contractors

Companies winning under the same main NAICS code.

ContractorAwardsObligated
California Institute of Technology

UEI YC1YP79BFD19

419$20.1B
The Aerospace Corporation

UEI YA8LJBJCND19

74$9.4B
Lockheed Martin Corp

UEI CQWLW9XRQTH5

15$8.3B
The Johns Hopkins University Applied Physics Laboratory LLC

UEI C1HBCJ9RMBV3

793$7.7B
Lockheed Martin Corp

UEI FYHNA5WC8XD7

13$7B
The Mitre Corporation

UEI DMHDNDCPWUD1

205$6.2B

Stop checking this page by hand

Matched, not listed

Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.

Earlier than the RFP

Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.

A draft, not a link

For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.

Build a matching profile

Questions people ask

What is Duke University's UEI?

TP7EK8DZV6N5. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.

How much has Duke University won in federal contracts?

$573M obligated across 71 awards in Captivaq's records, most of it from National Institutes of Health. That covers contracts of $1M or more active since October 2023, so the full history is larger.

Which Duke University contracts end soon?

12 awards end in the next 18 months, listed on this page. Expiring contracts are often recompeted, which is the opening for a competitor or a teaming partner.

Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.

Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.